We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Novel Label-Free Protein Assay System Certified Compatible with CCD Spectrometer Microplate Readers

By LabMedica International staff writers
Posted on 08 Aug 2012
Print article
Image: The SPECTROstar Omega microplate reader is fully compatible with the SoPRano assay system (Photo courtesy of BMG Labtech / PharmaDiagnostics).
Image: The SPECTROstar Omega microplate reader is fully compatible with the SoPRano assay system (Photo courtesy of BMG Labtech / PharmaDiagnostics).
Several instruments manufactured by one of Europe's leading producers of microplate spectrophotometers have been certified as to being completely compatible with a novel, label-free protein assay system.

SPECTROstar Nano, SPECTROstar Omega, FLUOstar Omega, POLARstar Omega, and PHERAstar FS are microplate readers equipped with CCD (charge-coupled device) spectrometers. These instruments, made by the dedicated manufacturer of microplate readers BMG Labtech (Ortenberg,Germany) have been certified as being fully compatible with PharmaDiagnostics' (Zellik, Belgium) SoPRano assay system.

The SoPRano assay is based on an adaptation of surface plasmon resonance (SPR) technology known as localized surface plasmon resonance (LSPR). In this system, gold nano rods (GNR) in solution are coated with the protein of interest. When the target protein molecules attached to the surface of the GNR’s interact with a ligand, a highly reproducible and dose dependent absorbance change occurs, which manifests as a redshift in the maximum absorbance wavelength. This is measured on a standard absorbance plate reader in either 96- or 384-well format.

The SoPRano assay system does not require specialized SPR detection equipment. Instead, a standard liquid handler and UV-Vis plate reader (scanning) capable of signal measurement up to 1000 nm are all that are needed.

This technology is broadly enabling and has been adapted for a variety of applications in basic research, pharmaceutical discovery, and quality control. Current applications include real-time kinetics, antibody-antigen interactions, epitope mapping; protein-protein interaction assays, and small molecule protein-protein inhibition assays.

Dr. E. J. Dell, international marketing director at BMG Labtech, said, “Since the whole absorbance spectrum redshifts when molecules bind to the SoPRano GNR surface, a whole spectrum needs to be measured. In less than one second per well and at a resolution of one nanometer, our CCD spectrometer microplate readers can instantly capture an entire absorbance spectrum (220-1,000 nm). Other microplate readers have to ‘build’ the spectrum, this can take tens of seconds (or even minutes) and it is usually at a lower resolution. This makes BMG Labtech’s CCD spectrometer microplate readers perfect for the SoPRano label-free assay.”

“The BMG Labtech spectrometer technology and dedicated SoPRano software enhance data quality and ease of use for SoPRano users. The combination of the BMG Labtech readers and SoPRano technology now deliver label-free, high quality protein-protein interactions analysis at a cost level an order of magnitude lower than specialist SPR systems, making this valuable technique available to any life science lab”, said Julian Abery, vice president for business development at PharmaDiagnostics.

Related Links:
BMG Labtech


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.